If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mizuki Morita is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Biological Science Disciplines Medicine & Life Sciences
Databases Medicine & Life Sciences
Semantics Medicine & Life Sciences
Japan Medicine & Life Sciences
Support vector machines Engineering & Materials Science
Interoperability Engineering & Materials Science
Ontology Engineering & Materials Science
Natural Language Processing Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 463 Citations
  • 6 h-Index
  • 11 Article
  • 4 Conference contribution
  • 2 Review article
1 Citation (Scopus)
Sudden Cardiac Death
Equipment and Supplies
3 Citations (Scopus)

Tweet Classification Toward Twitter-Based Disease Surveillance: New Data, Methods, and Evaluations

Wakamiya, S., Morita, M., Kano, Y., Ohkuma, T. & Aramaki, E., Feb 20 2019, In : Journal of medical Internet research. 21, 2, p. e12783

Research output: Contribution to journalArticle

Open Access
Natural Language Processing
Social Media
2 Citations (Scopus)

Medical attitudes survey for female dystrophinopathy carriers in Japan

Kobayashi, M., Hatakeyama, T., Ishizaki, M., Adachi, K., Morita, M., Yonemoto, N., Matsumura, T., Toyoshima, I. & Kimura, E., Jan 1 2018, In : Internal Medicine. 57, 16, p. 2325-2332 8 p.

Research output: Contribution to journalArticle

Genetic Testing
Duchenne Muscular Dystrophy

Effects of Cold Ischemia on RNA Stability and Quality of Lung Tissues Based on Standard PREanalytical Code Categorization

Matsubara, T., Tomida, S., Sou, J., Uwabo, T., Mori, Y., Morita, M., Nasu, Y., Kanazawa, S. & Toyooka, S., Oct 1 2017, In : Biopreservation and Biobanking. 15, 5, p. 484-486 3 p.

Research output: Contribution to journalArticle

37 Citations (Scopus)

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations

Suzawa, K., Toyooka, S., Sakaguchi, M., Morita, M., Yamamoto, H., Tomida, S., Ohtsuka, T., Watanabe, M., Hashida, S., Maki, Y., Sou, J., Asano, H., Tsukuda, K. & Miyoshi, S., Jan 1 2016, In : Cancer Science. 107, 1, p. 45-52 8 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Non-Small Cell Lung Carcinoma
Epidermal Growth Factor Receptor